187 related articles for article (PubMed ID: 15482827)
1. Material-specific thrombin generation following contact between metal surfaces and whole blood.
Hong J; Azens A; Ekdahl KN; Granqvist CG; Nilsson B
Biomaterials; 2005 Apr; 26(12):1397-403. PubMed ID: 15482827
[TBL] [Abstract][Full Text] [Related]
2. The role of whole blood in thrombin generation in contact with various titanium surfaces.
Thor A; Rasmusson L; Wennerberg A; Thomsen P; Hirsch JM; Nilsson B; Hong J
Biomaterials; 2007 Feb; 28(6):966-74. PubMed ID: 17095084
[TBL] [Abstract][Full Text] [Related]
3. Blood interactions with noble metals: coagulation and immune complement activation.
Hulander M; Hong J; Andersson M; Gervén F; Ohrlander M; Tengvall P; Elwing H
ACS Appl Mater Interfaces; 2009 May; 1(5):1053-62. PubMed ID: 20355891
[TBL] [Abstract][Full Text] [Related]
4. Titanium is a highly thrombogenic biomaterial: possible implications for osteogenesis.
Hong J; Andersson J; Ekdahl KN; Elgue G; Axén N; Larsson R; Nilsson B
Thromb Haemost; 1999 Jul; 82(1):58-64. PubMed ID: 10456455
[TBL] [Abstract][Full Text] [Related]
5. Distinctive regulation of contact activation by antithrombin and C1-inhibitor on activated platelets and material surfaces.
Bäck J; Lang MH; Elgue G; Kalbitz M; Sanchez J; Ekdahl KN; Nilsson B
Biomaterials; 2009 Dec; 30(34):6573-80. PubMed ID: 19783299
[TBL] [Abstract][Full Text] [Related]
6. In vitro assessment of blood compatibility: residual and dynamic markers of cellular activation.
Johnson G; Curry B; Cahalan L; Prater R; Beeler M; Gartner M; Biggerstaff J; Cahalan P
J Biomater Appl; 2013 May; 27(8):925-36. PubMed ID: 22210807
[TBL] [Abstract][Full Text] [Related]
7. Covalently immobilized thrombomodulin inhibits coagulation and complement activation of artificial surfaces in vitro.
Sperling C; Salchert K; Streller U; Werner C
Biomaterials; 2004 Sep; 25(21):5101-13. PubMed ID: 15109834
[TBL] [Abstract][Full Text] [Related]
8. Thrombin, kallikrein and complement C5b-9 adsorption on hydrophilic and hydrophobic titanium and glass after short time exposure to whole blood.
Yahyapour N; Eriksson C; Malmberg P; Nygren H
Biomaterials; 2004 Jul; 25(16):3171-6. PubMed ID: 14980412
[TBL] [Abstract][Full Text] [Related]
9. Blood coagulation on biomaterials requires the combination of distinct activation processes.
Sperling C; Fischer M; Maitz MF; Werner C
Biomaterials; 2009 Sep; 30(27):4447-56. PubMed ID: 19535136
[TBL] [Abstract][Full Text] [Related]
10. Surface-attached PEO in the form of activated Pluronic with immobilized factor H reduces both coagulation and complement activation in a whole-blood model.
Andersson J; Bexborn F; Klinth J; Nilsson B; Ekdahl KN
J Biomed Mater Res A; 2006 Jan; 76(1):25-34. PubMed ID: 16250010
[TBL] [Abstract][Full Text] [Related]
11. Effects on blood compatibility in vitro by combining a direct P2Y12 receptor inhibitor and heparin coating of stents.
Christensen K; Larsson R; Emanuelsson H; Elgue G; Larsson A
Platelets; 2006 Aug; 17(5):318-27. PubMed ID: 16928604
[TBL] [Abstract][Full Text] [Related]
12. Blood plasma contact activation on silicon, titanium and aluminium.
Arvidsson S; Askendal A; Tengvall P
Biomaterials; 2007 Mar; 28(7):1346-54. PubMed ID: 17156838
[TBL] [Abstract][Full Text] [Related]
13. A new in vitro model to study interaction between whole blood and biomaterials. Studies of platelet and coagulation activation and the effect of aspirin.
Hong J; Nilsson Ekdahl K; Reynolds H; Larsson R; Nilsson B
Biomaterials; 1999 Apr; 20(7):603-11. PubMed ID: 10208402
[TBL] [Abstract][Full Text] [Related]
14. Hirudin versus heparin for use in whole blood in vitro biocompatibility models.
Bexborn F; Engberg AE; Sandholm K; Mollnes TE; Hong J; Nilsson Ekdahl K
J Biomed Mater Res A; 2009 Jun; 89(4):951-9. PubMed ID: 18470919
[TBL] [Abstract][Full Text] [Related]
15. The creation of an antithrombotic surface by apyrase immobilization.
Nilsson PH; Engberg AE; Bäck J; Faxälv L; Lindahl TL; Nilsson B; Ekdahl KN
Biomaterials; 2010 Jun; 31(16):4484-91. PubMed ID: 20211488
[TBL] [Abstract][Full Text] [Related]
16. Nanoporesize affects complement activation.
Ferraz N; Nilsson B; Hong J; Karlsson Ott M
J Biomed Mater Res A; 2008 Dec; 87(3):575-81. PubMed ID: 18186072
[TBL] [Abstract][Full Text] [Related]
17. In vitro blood reactivity to hydroxylated and non-hydroxylated polymer surfaces.
Sperling C; Maitz MF; Talkenberger S; Gouzy MF; Groth T; Werner C
Biomaterials; 2007 Sep; 28(25):3617-25. PubMed ID: 17524475
[TBL] [Abstract][Full Text] [Related]
18. The ability of surface characteristics of materials to trigger leukocyte tissue factor expression.
Fischer M; Sperling C; Tengvall P; Werner C
Biomaterials; 2010 Mar; 31(9):2498-507. PubMed ID: 20035991
[TBL] [Abstract][Full Text] [Related]
19. Assessing the in vitro biocompatibility of a novel carbon device for the treatment of sepsis.
Sandeman SR; Howell CA; Phillips GJ; Lloyd AW; Davies JG; Mikhalovsky SV; Tennison SR; Rawlinson AP; Kozynchenko OP; Owen HL; Gaylor JD; Rouse JJ; Courtney JM
Biomaterials; 2005 Dec; 26(34):7124-31. PubMed ID: 15967498
[TBL] [Abstract][Full Text] [Related]
20. Activation of human leukocytes on tantalum trabecular metal in comparison to commonly used orthopedic metal implant materials.
Schildhauer TA; Peter E; Muhr G; Köller M
J Biomed Mater Res A; 2009 Feb; 88(2):332-41. PubMed ID: 18286637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
